PET Alzheimer’s coverage query renewed
This article was originally published in The Gray Sheet
Executive Summary
CMS accepts UCLA's revised request for a national coverage decision after the agency issued a non-coverage determination in April (1"The Gray Sheet" April 21, 2003, p. 4). UCLA now is seeking Medicare coverage of PET scans in patients "with a gradually progressive decline in one or more cognitive domains" and/or "cognitive impairment due to memory loss, who have had a comprehensive physical including neurological testing and who do not suffer from severe dementia." CMS expects to complete the review by Jan. 7...
You may also be interested in...
CMS Says No To PET For Alzheimer’s, But Leaves Door Open For Future Studies
CMS continues to support research on FDG-PET in the diagnosis of Alzheimer's disease (AD), despite an April 16 non-coverage decision
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.